Originally published at Post Online Media
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced the appointment of Randy Thurman to its board of directors.With more than 30 years of health care industry experience, Mr. Thurman brings a wealth of operational, financial, and business development expertise to Arno. Mr. Thurman became an Operating Partner for AEA Investors LP in October 2012 and previously held the same role with New Mountain Capital LLC since 2008. Mr. Thurman is also Executive Chairman of CogentHMG and was previously Founder, Chairman & CEO of VIASYS Healthcare, Inc.